ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 83 filers reported holding ADURO BIOTECH INC in Q2 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,000 | 0.0% | 5,545 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $13,000 | -13.3% | 5,545 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $15,000 | +114.3% | 5,545 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | +16.7% | 5,545 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -33.3% | 5,545 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | -59.1% | 5,545 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $22,000 | +46.7% | 5,545 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $15,000 | -63.4% | 5,545 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $41,000 | +5.1% | 5,545 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $39,000 | +18.2% | 5,545 | +55.1% | 0.00% | 0.0% |
| Q1 2018 | $33,000 | +22.2% | 3,574 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $27,000 | -37.2% | 3,574 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $43,000 | +4.9% | 3,574 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $41,000 | +36.7% | 3,574 | +29.4% | 0.00% | +100.0% |
| Q1 2017 | $30,000 | – | 2,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |